Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer

Authors: H Nakazato, H Ichihashi, T Kondo

Journal: Gan To Kagaku Ryoho

Study Design: Randomized controlled trial

• Participants: 168 patients with curatively resected gastric cancer and 111 with colorectal cancer
• Intervention: Carboquone (CQ) and/or PSK (Krestin) at 2 g/m2 administered in varying regimens for 55 weeks
• Outcome measures: Survival rate

Summary: The study found that the combination of CQ and PSK improved survival rates in patients with stage III gastric cancer and Dukes C colorectal cancer, especially in those receiving more than six treatment courses.